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ABSTRACT OF THE DISSERTATION 
Effect of Passive Vibration in Skin Blood Flow, Skin Temperature and Blood Pressure In 
Good Glycemic Control and Poor Glycemic Control Type 2 Diabetics 
 
by 
Kanikkai Steni Balan Sackiriyas 
Doctor of Science, Graduate Program in Physical Therapy 
Loma Linda University, March 2013 
Dr. Everett B. Lohman, Chairperson 
 
Microcirculation regulated by the sympathetic system and vascular endothelium 
plays a significant role in the homeostasis of temperature and wound healing. Damage to 
the autonomic nervous system and endothelial system resulting from aging and diabetes 
decreases the potential of wound healing. Insulin resistance and impaired wound healing 
associated with type 2 diabetes can lead to diabetic foot ulceration (DFU). Factors such 
as the increased insulin resistance, impaired wound healing and DFU can increase the 
risk of amputation in type 2 diabetics (T2D). In research, passive vibration (PV) was 
effective in increasing skin blood flow (SBF) in healthy individuals as well as in good to 
fair glycemic control T2D. There has been no study performed to examine the effect of 
PV on (SBF), skin temperature (ST) and blood pressure (BP) in good glycemic control 
(GG) control and poor glycemic (PG) control T2D. The purpose of this study was to 
examine the effect of PV on SBF without adversely affecting the ST and BP in GG 
control and PG control T2D. This was done by assessing SBF using a MOOR full-field 
laser perfusion imager (MOOR FLPI) after the application of PV.  
Seventeen good glycemic control and fifteen poor glycemic control T2D 
participated in this study. The SBF, ST and BP were measured at the baseline. Then, the 
xv 
subjects received PV to their calf area and foot area on another side for about ten 
minutes. The second reading was measured immediately after the PV. The third 
measurement was taken after a ten minutes rest post the vibration application.  
Results from this study showed that PV significantly increased SBF in the calf 
area from baseline to immediately after vibration and baseline to 10 minutes post rest 
without adversely affecting the ST and BP in both GG control and PG control T2D.  
Also, the percent change of SBF in the foot area was higher in the GG control (91.3%) 
than in PG control T2D (32.6%). 
Results from this study suggest that PV can be a safe and alternative method in 
increasing SBF without increasing the risk of burns in GG control and PG control T2D.  
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CHAPTER ONE 
 
INTRODUCTION 
 
Diabetes Mellitus (DM) is a common metabolic disorder in which the pancreatic 
cells produce either no insulin or insufficient insulin, or the body cells do not respond to 
the insulin that is produced. It results in abnormal metabolism of carbohydrates, fats and 
proteins which leads to a high amount of glucose levels in the blood stream and in the 
urine (1). Diabetes has become a major health care problem in the United States (2), 
affecting millions of Americans each year (3). It is estimated that 25.8 million (8.3%) 
children and adults in the United States have diabetes and 10.9 million (26.9%) of the 
world population ≥65years have diabetes (1), (2). The Centers for Disease Control and 
Prevention (CDC) estimated that diagnosed diabetes is likely to increase 165 percent by 
2050 (1). 
Diabetes is one of the leading causes of disability and death from stroke and heart 
diseases. It is the seventh leading cause of death in the United States, according to a 
report published by the CDC (1), (2). The fact sheet released by the National Diabetes 
Information Clearinghouse reported that the care associated with diabetes has cost the 
United States a total of $174 billion (indirect costs and direct costs)  (1), (2). The medical 
expenses associated with diabetes are two times higher in diabetic individuals than in 
non-diabetics (2). Diabetes Mellitus is divided into four major types: Type 1, Type 2, 
Gestational, and Latent Autoimmune Diabetes in Adults (LADA) (1), (2), (3), (4). 
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Type 1 diabetes is an autoimmune disease in which the body’s system for fighting 
infection (the immune system) turns against the host cells. It attacks and destroys the 
insulin producing beta cells in the pancreas, resulting in the production of little or no 
insulin. Causes that are possibly associated with Type I diabetes include a T cell 
mediated autoimmune attack, hereditary influence, environmental factors, and viruses. 
Type 1 diabetes is most often present in children and the young adults (1), (4), (5). 
Patients are categorized as prediabetes when their blood glucose level is higher 
than the normal but lower than the level used for diagnosing diabetes. Thirty three 
percent (1 in 3 Americans) of people having prediabetes are likely to develop type 2 
diabetes within ten years if adequate steps are not taken (1), (2). In contrast, type 2 diabetes 
is a non-autoimmune disease (6). Type 2 diabetes is the most common form (90% to 95%) 
among all types of diabetes and is due to insulin resistance in which target cells do not 
use the insulin effectively, even though normal, or in some cases elevated levels of 
circulating endogenous insulin are present in the body. Eventually, insulin production 
decreases after several years, leading to increased build up of glucose levels in the body 
(1). 
Gestational diabetes usually occurs late in the pregnancy due to associated 
hormonal production or insulin shortage. Women with gestational diabetes have 40% to 
60% chance of developing into type 2 diabetes within 5 to 10 years (1). 
Latent autoimmune diabetes in adults (LADA) is also called type 1.5 diabetes or 
double diabetes, because it shows combined signs of both type 1 and type 2 diabetes (1). 
The LADA is an autoimmune disease and shows the clinical symptoms of type 1 
diabetes. According to the Immunology of Diabetes Society, there are three diagnostic 
3 
criteria for the LADA: 1) Adult age of onset (30 years of age); 2) presence of at least one 
autoantibody (GAD, ICA, IAA or IA-2), and 3) insulin dependence for the first six 
months after the diagnosis (7), (8). 
Regardless of the type of diabetes mellitus (DM), there are numerous 
complications associated with diabetes, including heart disease, stroke, high blood 
pressure, blindness, kidney disease, neuropathy, poor circulation, foot ulcers and 
amputation (2). The most common complication associated with diabetes is damage to the 
microcirculation and endothelial cells (9). Damage to endothelial cells reduces their ability 
to produce nitric oxide (NO) and decreases their sensitivity to NO, thereby leading to 
decreased skin blood flow (10), (11). Microangiopathy due to defects in the structure and 
function of the vessel wall, and impaired hemodynamic (hyper dynamic) circulation is a 
common feature in diabetes. Anatomical impairments of the vessel wall can include 
glycocalyx on the luminal side and protein deposition, smooth muscle cell proliferation 
on the abluminal side. Impaired hemodynamics resulting from increased plasma volume 
and viscosity, reduction in erythrocyte deformability, and aggregation of blood cells can 
lead to microangiopathy, a common characteristic in diabetes (12), (13). Endothelial 
glycocalyx reduces the internal diameter of the capillaries and reduces availability of 
oxygen delivery to the tissues by as much as 60% (13), (14). Capillary rarefaction due to 
hypertension in diabetes increases diffusion distance between capillaries and target cells, 
slowing down diffusion rates of oxygen and glucose between those structures (13). 
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Blood Circulation 
 
The entire blood circulation in the body is about 5-6 L/m at rest. A total of 4.75 
L/m is distributed to the following organs; liver and kidneys 2,500 ml/min, skeletal 
muscles 1,000 ml/min, brain 750 ml/min, heart 250 ml/min, and skin 250 ml/min 
(thermo-neutral environments). The remaining cardiac output is delivered to other organs 
(15), (16). Blood flow is regulated by factors such as arterial pressure, vascular resistance, 
total peripheral resistance (TPR), blood viscosity, and length and radius of the blood 
vessel. Blood flow increases proportionately with increasing arterial pressure and 
decreases with vascular resistance. The principal factor in regulation of blood flow is the 
radius of the vessel since all other factors do not change significantly in a healthy 
individual. For example, a decrease in the diameter of the blood vessel to half of its size 
increases resistance and reduces blood flow by 16 times when all other factors are 
constant (15). 
The vascular system is divided into larger conduit, medium resistance and smaller 
micro vessels. Resistance vessels are responsible for maintaining blood pressure. Micro 
vessels are entirely different from macro and medium vessels and represent “nutritive” 
structures  (13), (17). 
 
Regulation of Blood Pressure 
 
Blood flow is regulated by two classes of mechanisms; those that are extrinsic, 
and those that are intrinsic to the system proper. Extrinsic mechanisms act through the 
autonomic nervous system and endocrine system, and produce more generalized effects 
in many regions of the body. They directly affect resistance and blood flow. Intrinsic 
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mechanisms within individual tissues have “built in” (localized) effects on vascular 
resistance and blood flow. Intrinsic mechanisms regulate blood circulation through 
myogenic and metabolic control (15). 
 
Extrinsic Control 
 
The autonomic nervous system controls blood flow through sympathetic (alpha-
adrenergic, beta-adrenergic) and parasympathetic (cholinergic) innervation. Endocrine 
system controls blood flow through hormones such as Angiotensin II, Vasopressin 
(ADH), Histamine, Bradykinens, and Prostaglandins (15). 
 
Intrinsic Control 
 
Intrinsic mechanisms control circulation through auto regulation. Autoregulation 
through myogenic and metabolic regulation allows the organ to have some independent 
control to maintain a constant blood flow rate despite variations in the systemic blood 
pressure (15). 
 
Skin Circulation 
 
Skin circulation is a highly regulated mechanism that plays a vital role in the 
regulation of blood pressure, temperature and healing, and is controlled by the central 
nervous system and local metabolic states of tissues (16), (18), (19). Micro vessels consist of a 
single terminal feeding arteriole that branch into a group of 15-20 smaller diameter 
capillaries (13), (17). Microcirculation carries fuel and nutrients to remote cells and involves 
in the exchange of waste products with the surrounding tissues. It is influenced by 
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vascular permeability which in turn depends on the structure of vessel walls and existing 
hydrostatic pressure differences between arteriolar and venular segments (13).  The 
metabolic, physical and nervous systems regulate the microcirculation. Therefore, not the 
quantity but the distribution of blood in the micro vascular bed is a primary determinant. 
A continuous change of blood flow in relation to amount, velocity and direction due to 
local metabolic needs is finely regulated by vasoconstriction and vasodilation in the 
microcirculation. This is achieved through the arteriolar myogenic response, 
venoarteriolar reflex, and precapillary arteriolar vasomotion (13), (20). Failure in these 
mechanisms can lead to hyperperfusion and subsequent hypertension in the micro 
vascular bed. 
The architecture of the micro vascular system is not uniform and varies in 
glabrous (non hairy) and nonglabrous (hairy) skin (21). The glabrous skin (palms, soles, 
lips, face, tips of fingers and toes) has numerous thick walled thermo-regulating 
arteriovenous anastomoses (AVA) (22). It is mainly innervated by sympathetic 
vasoconstrictor nerves (16), (21), (23), (24). Numerous larger diameter arterioles and venules in 
these areas  allow low resistance, high blood flow directly from the arterioles to venules 
(16), (21), (25), (26), (27), (28). In contrast to that, the nonglabrous skin (dorsal area of hand, foot) 
has more nutritive (NUTR) perfusion through small capillaries with fewer AVA and is 
controlled by both the sympathetic vasoconstrictor and vasodilator nerves (24), (29). These 
differences may lead to differential skin blood flow rates. 
Capillaries in the microcirculation have only one single endothelial cell layer on 
their basement membrane (13). Vascular endothelial cells are placed in between the blood 
and surrounding vascular smooth muscles (30), (31). They secrete fat soluble chemicals such 
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as vasodilators and vascular relaxation factors (27), (32). These chemicals diffuse into the 
blood and the vascular smooth muscles, and the balance between these factors maintains 
the normal skin blood flow. Any increase or decrease in these factors in one direction can 
change the luminal size of the arterioles and thereby leading to increased or decreased 
blood flow (27), (32), (33), (34), (35), (36). 
Skin blood flow can be influenced by various factors such as tissue local pressure 
and occlusion, temperature, moist heat, aging and diabetes, vitamins, body mass index 
and race. Measuring SBF helps to understand the function of various organs and their 
reaction to various stimuli and pharmacological interventions (37). Skin blood flow can be 
measured by direct capillary pressure measurement, transcutaneous oxygen measurement, 
radionuclide techniques, temperature (biopac thermostat, radiometric, thermography, 
microwave radiometry and thermal clearance or conductivity measurements), ultrasound, 
dermofluorometry, laser doppler flowmetry, photoplethysmography, and capillary 
microscopy (38). 
 
Vibration 
 
Mechanical oscillations applied randomly or periodically are known as vibration. 
Vibration can be applied to the whole body or to a specific region of the body. Vibration 
can be divided into active and passive vibration. In active vibration, the mechanical 
vibration is delivered horizontally to the body part and requires that the patient actively 
participate in weight bearing and exercise (39). 
Passive vibration does not require the patient to bear weight and the mechanical 
oscillations are delivered perpendicularly with the subjects relaxed (39). Studies conducted 
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on vibration reported changes associated with the vibration such as increased muscular 
strength (40), (41), (42), (43), (44), improved muscle performance and balance (45), (46), (47), 
increased muscle flexibility (48), increased body composition (42), (49), improvements in 
human athletic performance such as running parameters and jumping, and improved 
circulation (40), (47), (50), (51). 
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Abstract 
 
Objective 
 
To study the effect of passive vibration on skin blood flow (SBF) in two groups of 
diabetics: good control and poor control.  
 
Materials and Methods  
 
Passive vibration using Power Plate® was applied to the calf area and the plantar 
surface of the foot. Fifteen good glycemic control (HbA1c < 7.5%) and twelve poor 
glycemic control (HbA1c > 9%) type 2 diabetics participated in this study. The SBF was 
measured using a MOOR full-field Laser perfusion imager before, immediately after 
vibration and 10 minutes post the vibration application. 
 
Results  
 
There was a significant difference in the mean SBF for the calf area from baseline 
to immediately after vibration in both good glycemic control and poor glycemic control 
diabetics. The mean calf SBF was almost doubled in good glycemic control diabetics 
from baseline (38.9 flux) to immediately after vibration (69.5 flux) (p=.03). The mean 
calf SBF was more than doubled in poor glycemic control diabetics from baseline (32.9 
flux) to immediately after vibration (77.9 flux) (p=.02). However, no significant change 
in mean SBF was detected over time for the foot area in good glycemic control and poor 
glycemic control diabetics (p<.05). Baseline resting SBF was higher in foot than calf area 
for both good glycemic control and poor glycemic control type 2 diabetics. The percent 
change from baseline to immediately after vibration in the calf SBF was higher in poor 
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glycemic control (132.6%) than the good glycemic control diabetics (76%). Foot SBF 
showed a higher percent increase in the good glycemic control (72.3%) than the poor 
glycemic control diabetics (32.1%). The percent increase was 100.3% in the calf SBF and 
55% in foot SBF irrespective of group. 
 
Conclusion  
 
In this study, we observed a significant change in mean calf SBF from baseline to 
immediately after vibration. Also, the higher percent change of calf SBF and foot SBF 
was observed from baseline to immediately after vibration. These results suggest that 
passive vibration may be an effective therapy for increasing lower extremity circulation 
in both good glycemic control and poor glycemic control type 2 diabetics. 
 
Key Words 
 
Vibration, MOOR FLPI, Skin Circulation, Good Glycemic Control, Poor Glycemic 
Control, Diabetes Mellitus, Full-field Laser Perfusion Imager. 
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Introduction 
 
Diabetes Mellitus (DM) is a major health care problem and can lead to stroke and 
heart disease (1). Millions of Americans are affected by DM. The associated medical 
expenses and death rate is two times higher in diabetics than non-diabetics (1), (2). The 
highest incidence of diabetes is known as type 2 diabetes (T2D) (90% to 95 %). This 
typically results from the inadequate use of insulin by target cells even though circulating 
insulin level maybe normal or elevated (1), (2), (3). According to the Center for Disease 
Control and Prevention (CDC), DM is classified into good glycemic (HbA1c <7.5%), fair 
glycemic (HbA1c ≥7.5% to ≤9%) and poor glycemic control (HbA1c >9%) based on the 
Hemoglobin A1c (HbA1c) level (4), (5). 
 
Circulation 
 
Tissue healing is an intricate process and primarily depends on blood circulation 
(6). Skin circulation is under the control of central nervous system and tissue’s metabolic 
state (7). Resting skin blood flow is dependent on factors such as skin moisture, tissue 
pressure, age, vitamins, race, diabetes, and exposure to free radicals (8). 
Aging, body mass index (BMI) and diabetes affect endothelial cells and 
autonomic function, hence decreases microcirculation (6), (9), (10). Complex architecture of 
skin is responsible for differential circulation rate. Glabrous skin (palms, soles) has thick 
walled arteriovenous anastomoses (AVA). Numerous larger arteries and venules in these 
areas allow low resistance and high skin blood flow (SBF) rate. Whereas, non-glabrous 
skin (forearm, calf, dorsal hand) has more nutritive (NUTR) perfusion and is served by 
capillaries with fewer AVA (11), (12), (13).  
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In research, vibration is being used to increase skin circulation. Research supports 
the use of passive vibration (PV) to improve skin blood flow (SBF) without increasing 
the risk of burns. Lohman et al., (2012) showed that PV significantly improved SBF in 
hairy and non-hairy skin both in good to fair glycemic control diabetics and non-diabetics 
(14), (15), (16). The purpose of this study was to examine the effect of PV on SBF in good 
glycemic control versus poor glycemic control type 2 diabetics. We hypothesized that 
passive vibration induced increase in SBF in calf and foot were higher in good glycemic 
control than the poor glycemic control diabetics. The secondary hypothesis was that 
passive vibration induced increase in SBF was higher in calf (non-glabrous) than the foot 
(glabrous) in both good glycemic control and poor glycemic control type 2 diabetics. 
 
Material and Methods 
 
Study Population 
 
Type 2 diabetics between the age ranges of 18-75 years invited to participate in 
this study. Subjects with neurological disorders, orthopedic disorders, bleeding disorders, 
leg ulcer, chronically exposed to vibration, cardiovascular diseases, deep vein thrombosis 
(DVT), or pregnant were excluded. Thirty two subjects were recruited from the Diabetes 
Support Group and from the Diabetes Treatment Center at Loma Linda University (LLU) 
Medical Center. Five subjects were excluded because they did not meet the inclusion 
criteria. Subjects were assigned into one of two groups: Good glycemic control diabetics 
and Poor glycemic control diabetics. Both groups received passive vibration to their calf 
area and the opposite foot area on the same day. The LLU’s institutional review board 
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approved all procedures and subjects signed statements of informed consent (Appendix 
A). 
Instrumentation 
 
A Physio Plate® (Domino S.R.L, San Vendemiano, Italy) was used to deliver 
passive vibration at a frequency of 50 Hz for a total number of ten cycles (one cycle= 60s 
working time: 2 s rest time) for a total of approximately ten minutes (Figure 1). A MOOR 
full-filed Laser perfusion Imager (FLPI) (MOOR FLPI V 2.1, Oxford, England) was pre-
warmed for about 30 minutes to stabilize measurements and was used to measure SBF 
non-invasively (Figure 2). The FLPI uses a red light laser beam applied perpendicularly 
to capture SBF and blood flow was measured in “Flux” unit.  
 
 
Figure 1. Physio Plate® vibration platform. 
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Figure 2. MOOR Full-field Laser Perfusion Imager (FLPI). 
 
Procedure 
Screening 
 
The testing room temperature was maintained at 71.6°F-75.2°F (22°-24° C) for 
about 30 minutes before the subject enters. A 30 minutes rest period in supine position 
was given to subjects to stabilize their blood flow before intervention. Subjects were 
screened for exclusion and demographic data was collected (Appendix B). Subjects were 
screened for possible DVT using the Well’s criteria (17). Subjects with a score of ≥2 (high 
risk) were excluded. 
Cutaneous sensation was checked using a Semmes-Weinstein Monofilament 
(North Coast Medical, Inc, Morgan Hill, CA, USA) and the response, color of the handle 
and notations were noted on the sensory foot mapping form (Appendix C). Vibration 
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sense was checked with a 128 Hz tuning fork and subjects with a score of 2 (absent 
sensation) were excluded. 
 
Testing 
 
Subjects were asked to lie prone on a plinth. A square shaped 3 cm x 3 cm area 
was marked on the posterior aspect of the calf (muscle belly) and on the plantar aspect of 
the first three (1-3) metatarsal heads to capture SBF. Baseline SBF was measured in the 
calf area using the FLPI (Figure 3). Then, subjects received passive vibration to their calf 
for ten minutes (Figure 4). The second reading was taken immediately after vibration. 
Subjects were given a ten minutes rest before the third reading was taken. The same 
procedures were repeated for foot on the opposite leg (Figure 5 & Figure 6). 
 
22 
 
Figure 3. SBF measurement in the calf area. 
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Figure 4. Calf area vibration. 
 
 
Figure 5. Foot area vibration. 
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Figure 6. SBF measurement in the foot area. 
 
Data Analysis 
 
Data was analyzed using SPSS version 20.0 (18). One sample Kolmogorov 
Smirnov test was used to examine the distribution of the continuous variables. Chi-square 
test of independence was used to compare the proportions of males & females, ethnicity 
and levels of physical activity by group. We compared mean age and body mass index 
(BMI) by group using independent t-test. Mixed factorial analysis of variance was used to 
compare the effect of passive vibration on SBF from baseline to immediately after 
vibration and 10 minutes post rest in good glycemic control and poor glycemic control 
T2D subjects’ calf and foot. Significant differences were further examined with 
Bonferroni test. The level of significance was set at p<.05.  
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Results 
 
Fifteen good glycemic control and twelve poor glycemic control type 2 diabetics 
participated in the study. The results of the Kolmogorov Smirnov test showed the 
distribution of age, BMI and SBF were approximately normal. There were no significant 
differences between the good glycemic and poor glycemic control diabetics in terms of 
gender, race, physical activity, age and BMI (p>.05) (Table 1). 
 
Table 1. Distribution of demographic data by group (N=28). 
Variables  Good (n=16) Poor (n=12) p-value 
Gender† Male 9 (56.2%) 6 (50%) .74 
Female 7 (43.8%) 6 (50%)  
Ethnicity† White 7 (70%) 3 (30%) .49 
Hispanic 4 (66.79%) 2 (33.3%)  
Others¶ 2 (33.3%) 6 (66.7%)  
African American 2 (66.7%) 1 (33.3%)  
Physical activity† 
 
Very light 3 (37.5%) 5 (62.5%) .43 
Light 5 (71.4%) 2 (28.6%)  
Moderate & Heavy 8 (61.5%) 5 (38.5%)  
Age (Mean±SD)*  62.3±11.4 56.9±7.7 .17 
BMI (Mean±SD)*  31.1±5.6 32.0±6.8 .71 
†: Chi-square test 
*: Independent t test 
¶: Others: Asians, Middle eastern 
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Good Glycemic Control 
 
There was a significant change in mean calf SBF over time in good glycemic 
control diabetics (F2, 30=6.71, p=.02) (Table 2). A significant change was seen between 
baseline and immediately after vibration (p=.03) and between baseline and 10 minutes 
post rest (p=.03). However, there was no significant change in mean foot SBF over time 
in good glycemic control diabetics (F2, 30=2.6, p=.11). The mean SBF in the good 
glycemic control was significantly higher in foot than in calf at baseline (137.5±22.4 vs 
38.9±2.3; p<.001), immediately after vibration (187.0±29.2 vs 69.5±12.5; p<.001) and 10 
minutes post rest (142.1±21.8 vs 66.8±11.6; p<.01) (Figure 7). 
 
 
Figure 7. Changes in mean±SE† of SBF† by site in good glycemic control 
diabetics over time. 
†SBF: Skin blood flow 
†SE: Standard error 
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Poor Glycemic Control 
 
There was a significant change in mean calf SBF over time in poor glycemic 
control diabetics    (F2, 22=9.8, p=.01) (Table 2). A significant change was detected 
between baseline and immediately after vibration (p=.02), between baseline and 10 
minutes post rest (p=.01). There was no significant change in mean foot SBF over time in 
poor glycemic control diabetics (F2, 30=.04, p=.91). The mean SBF in the poor glycemic 
control was significantly higher in foot than in the calf at baseline (157.6±33.4 vs 
32.9±2.6; p<.01), immediately after vibration (163.8±32.3vs 77.9±15.5; p=.03) and 10 
minutes post rest (160.1±37.0 vs 70.9±12.5; p=.04) (Figure 8). 
 
 
Figure 8. Changes in mean±SE† SBF† by site in poor glycemic control 
diabetics over time. 
 
†SBF: Skin blood flow 
†SE: Standard error 
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Table 2. Mean (SE†) skin blood flow over time by group and site. 
Site Group Baseline 
Immediately 
after 
vibration 
10 min post 
rest p-value* 
Calf 
Good 38.9(2.3) 69.5(12.5) 66.8(11.6) .02 
Poor 32.9(2.6) 77.9(15.5) 70.9(12.5) .01 
Foot 
Good 137.5(22.4) 187.0(29.2) 142.1(21.8) .11 
Poor 157.6(33.4) 163.8(32.3) 160.1(37.0) .91 
*Analysis of variance 
†SE: Standard error 
 
 
 
Good Glycemic Control vs. Poor Glycemic Control 
 
There was a significant difference in mean calf SBF over time in both good 
glycemic control and poor glycemic control diabetics (F2, 52=16.6, p=.001). However, 
there was no significant difference between groups (F2, 30=.03, p=.90). Based on the 
Bonferroni test, there was a significant difference in calf SBF between baseline and 
immediately after vibration (p=.001) and between baseline and 10 minutes post rest 
(p=.001) in both good glycemic control and poor glycemic control diabetics. There was 
no significant difference in mean calf SBF between immediately after vibration and 10 
minutes post rest (p=.40). There was no significant difference in foot SBF over time in 
both good glycemic control and poor glycemic control diabetics (F2, 52=1.57, p=.22). 
 
Discussion 
 
The diabetic foot ulcer (DFU) is the leading cause of amputation in diabetics and 
approximately 8% of diabetics tend to have peripheral vascular disease (PVD) at the time 
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of initial diagnosis (19). Peripheral vascular disease rapidly rises with age and duration of 
diabetes. The associated lower extremity amputation rate is 15 times higher in diabetics 
than non diabetics. In most cases, the lesion starts from a painless trauma in an insensate 
neuropathic foot. Healing of these lesions is thwarted by the presence of PVD. Lack of 
sufficient blood flow and decreased delivery of leukocytes impairs the function of some 
of tissue growth factors and antibiotics that are oxygen dependant, and increases the 
growth of highly destructive anaerobes in the infected tissues (19). Therefore, modalities 
that can increase even a small amount of circulation may play a clinically important role 
in the healing process. Studies from the department of physical therapy in Loma Linda 
University and others have shown that vibration can be effective in increasing SBF in 
diabetics as well as in non-diabetics (14), (15), (16), (20), (21), (22), (23), (24), (25). We believe that the 
increase in SBF may help in accelerating the healing process and the prevention of DFU.  
Contrary to our expectation, the study results did not meet our first hypothesis; 
there was no significant increase in SBF in the calf area and foot area in good glycemic 
control than in poor glycemic control diabetics. On the other hand, the results from this 
study supported our second hypothesis; SBF in the calf area was significantly increased 
more than the foot area in both the good glycemic control and the poor glycemic control 
diabetics as a result of passive vibration.   
In this study, mean foot SBF was higher than the calf at baseline, immediately 
after vibration and 10 minutes post rest in both good glycemic control and poor glycemic 
control. One possible explanation could be that the arteriolar myogenic response, 
vasoarteriolar reflex and precapillary arteriolar vasomotion in the microcirculation are 
impaired. Normally, all these mechanisms regulate the blood flow during daily 
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physiological stimuli such as local tissue metabolic needs and positional changes (upright 
position). Upright position increases hydrostatic pressure in the leg that triggers sensors 
in the vein to signal the arterioles to constrict. This phenomenon prevents excessive 
perfusion in the capillaries and the subsequent hypertension. This very important 
mechanism is deficient in both type 1 and type 2 diabetics (hemodynamic hypothesis) (26). 
This could be the reason why we observed higher mean SBF, over time, in foot than calf 
in both good glycemic control and poor glycemic control diabetics. This could also 
possibly explain why there was no significant change in foot SBF overtime due to passive 
vibration in both good glycemic control and poor glycemic control diabetics. 
Precapillary arteriolar vasomotion is a phenomenon in which tissues show a 
rhythmic, slow-wave and high amplitude changes in the arteriolar diameter.  This 
maintains the distribution of blood flowing through capillaries. Failure of this mechanism 
may fill capillaries permanently and allows no further reserve when the demand is 
increased. This function is impaired in many pathological conditions such as 
hyperinsulinaemia (diabetes) (26).  In this study, the percent change in calf SBF from 
baseline to post vibration was significantly higher in poor glycemic control (132.6%) 
than good glycemic control (76%) diabetics. There could be two possible explanations 
for this finding. The possible explanation could be the absence of vasomotion due to 
hyperinsulinaemia might be higher in poor glycemic control than good glycemic control 
diabetics. This could be the reason why we observed higher percent change in the calf 
area in poor glycemic control than in good glycemic control diabetics. On the other hand, 
the absence of vasomotion is more common in foot than calf. This suggests that calf SBF 
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in poor glycemic control might have responded well with the passive vibration. Further 
studies have to be done to analyze this phenomenon.  
The mean SBF in calf was almost doubled from baseline (38.9 flux) to 
immediately after vibration (69.5 flux) in good control control and was more than 
doubled from baseline (32.9 flux) to immediately after vibration (77.9 flux) in poor 
glycemic control diabetics. This implies that passive vibration was effective in increasing 
SBF in calf in both good glycemic control and poor glycemic control diabetics. However, 
no considerable change in the calf SBF was observed from immediately after vibration to 
10 minutes post rest in both good glycemic control and poor glycemic control diabetics. 
This finding suggests that effect of passive vibration was maintained more than ten 
minutes after the intervention. 
Although significant SBF changes have been documented in the calf, PV for 10 
minutes did not significantly increase skin blood flow in the foot; a common site of 
diabetic ulcers. The percent change of foot SBF from baseline to immediately after 
vibration was significantly higher in the good glycemic control (72.3%) as compared to 
the poor glycemic control (32.1%) diabetics. Hyperinsulinaemia and associated impaired 
vasomotion could be a possible reason why good glycemic control diabetics showed 
higher calf SBF than the poor glycemic control diabetics. However, from a clinical 
perspective, distribution of blood in the whole foot is an important factor although the 
quantity of blood flow is less in micro-vascular bed (26). Therefore, a 72.3% increase in 
the good glycemic control foot SBF and 32.1% increase in the poor glycemic control foot 
SBF imply that passive vibration to the foot in both good glycemic control and poor 
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glycemic control diabetics can be a good “head start” in maintaining healthy circulation 
in foot.  
In our study, we tried to minimize all the external factors that could mask the 
effect of passive vibration. However, we did not stop the subjects from taking their blood 
pressure and glucose control medications such as diuretics and metformin from a clinical 
perspective. These medications could lower blood pressure (27) and might have masked 
the effect of passive vibration. High fat meal also decreases blood flow (28) and may have 
masked the vibration’s effect if subjects had high fat meal before vibration. Future studies 
should focus on comparing the effect of vibration with and without high fat meal prior to 
vibration. We did not record the subject’s physical activity just prior to the vibration 
application although we recorded their general physical activity. Exercising before 
vibration can increase or decrease the skin blood flow based on the training activity (29) 
and thus may mask the effect of passive vibration.  All of these factors could have 
masked the real effect of passive vibration and can be avoided in the future studies. 
Future studies can also examine whether assessing blood flow in the whole foot rather 
than a single point for at least one minute. This would be helpful in understanding the 
blood distribution in the micro-vascular bed. 
 
Conclusion 
 
Findings of higher mean calf SBF overtime in both poor glycemic control and 
good glycemic control, higher percent change of calf SBF from baseline to immediately 
after vibration in poor glycemic control than good glycemic control and higher percent 
change of foot SBF from baseline to immediately after vibration in good glycemic 
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control than poor glycemic control suggest that passive vibration can be safely applied to 
maintain good circulation in the lower extremities. Although the observed increase in 
foot was less in poor glycemic control, the distribution not the quantity plays a vital part 
in the micro-vascular bed. 
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Abstract 
 
Objective 
 
To study the effect of passive vibration on skin blood flow (SBF), skin 
temperature (ST) and blood pressure (BP) in good glycemic control and poor glycemic 
control type 2 diabetics.  
 
Materials and Methods 
 
Seventeen good glycemic control (HbA1c < 7.5%) and fifteen poor glycemic 
control (HbA1c > 9%) type 2 diabetics received passive vibration to their calf and foot on 
the same day. The SBF, ST and BP were measured before, immediately after vibration 
and 10 minutes post the vibration application. 
 
Results  
 
There was a significant increase in the mean SBF in the calf from baseline to 
immediately after vibration in the good glycemic control and the poor glycemic control 
groups. The mean skin blood flow in the calf almost doubled from baseline (38.8 flux) to 
immediately after vibration (67.5 flux) and 10 minutes post rest (65.1 flux) in the good 
glycemic control diabetics (p=.02). The mean SBF in the calf more than doubled from the 
baseline (31.7 flux) to immediately after vibration (73.4 flux) and 10 minutes post rest 
(67.6 flux) in the poor glycemic control diabetics (p=.00). However, there was no 
significant difference in mean foot SBF over time in both good glycemic control and poor 
glycemic control diabetics. Baseline resting mean of SBF was higher in foot than in calf 
for both groups of diabetics. The percent change in calf SBF was higher in the poor 
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glycemic control (131.6%) than the good glycemic control diabetics (71.2%) from 
baseline to immediately after vibration. However, foot SBF showed higher percent 
increase in the good glycemic control (91.3%) than the poor glycemic control (32.6%) 
diabetics from baseline to immediately after vibration. The percent increase was 99.5% in 
the calf and 63.8% in the foot irrespective of group. There was no clinically significant 
difference in the mean calf and foot ST and BP in both groups of diabetics. 
 
Conclusion  
 
Based on the results observed in this study, we suggest that passive vibration can 
be safely administered to the calf area and the foot area without significantly increasing 
the risk of burns, skin temperature and blood pressure in both good glycemic control and 
poor glycemic control type 2 diabetics. 
 
Key Words 
 
 Good Glycemic Control, Poor Glycemic Control, Diabetes Mellitus, Passive Vibration, 
Skin Circulation, MOOR FLPI, Full-field Laser Perfusion Imager. 
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ABBREVIATIONS 
 
 
DM    Diabetes Mellitus 
T2D    Type 2 Diabetics 
HbA1c    Hemoglobin Assay A1c or Glycohemoglobin 
CDC    The Centers for Disease Control and Prevention 
BP    Blood Pressure 
AVA Arteriovenous Anastomoses 
NUTR Nutritive 
SBF    Skin Blood Flow 
BMI    Body Mass Index 
NTS    Nucleus Tractus Solitarii 
PV    Passive Vibration 
ST    Skin Temperature 
DVT Deep Vein Thrombosis 
LLU Loma Linda University 
FLPI Full-field Laser Perfusion Imager 
SPSS Statistical Product and Service Solutions 
ml Milliliter 
min Minute 
SBP    Systolic Blood Pressure 
PVD    Diastolic Blood Pressure 
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Introduction 
 
Diabetes Mellitus (DM) is a major health care problem around the world. 
According to the International Diabetes Federation, 371 million people are living with 
diabetes around the globe. North America and the Caribbean spent more healthcare 
dollars on diabetes than any other region in the world.  The Unites States of America is 
the third leading country with 24.1 million diabetics, with China (92.3 M) and India (63.0 
M) being the top two countries with diabetes (1). Medical expenses and death rate are two 
times higher in diabetics than non-diabetics (2), (3). Type 2 diabetes (T2D) is the most 
common type of diabetes mellitus (90% to 95% of all forms of diabetes) and results from 
the body’s inability to use the circulating insulin although circulating insulin level maybe 
normal or in some cases elevated (2), (3), (4). Hemoglobin Assay A1c or Glycohemoglobin 
is a reliable test that reflects the average control of glucose over the past three months (5). 
According to the Centers for Disease Control and Prevention (CDC), DM can be 
classified into good glycemic control (HbA1c <7.5%), fair glycemic control (HbA1c 
≥7.5% to ≤9%) and poor glycemic control (HbA1c >9%), based on the Hemoglobin A1c 
(HbA1c) level (6), (7).  
 
Circulation 
 
Skin circulation is a highly regulated phenomenon in response to various physical 
and humoral stimuli (8). It plays a key role in the regulation of temperature (9), baroreflex 
control of blood pressure (BP) (9) and tissue healing (10). The central nervous system and 
the metabolic state of tissues controls the skin circulation (11). The architecture of the 
micro vascular system is not uniform and varies in glabrous (non hairy) and nonglabrous 
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(hairy) skin (12). The glabrous skin (palms, soles, lips, face, tips of fingers and toes) has 
deeply located numerous thick-walled thermo-regulating arteriovenous anastomoses 
(AVA) (13). It is mainly innervated by sympathetic vasoconstrictor nerves (9), (12), (14), (15). 
Numerous larger diameter arterioles and venules in these areas  allow low resistance, 
high blood flow directly from the arterioles to venules (9), (12), (16), (17), (18), (19). In contrast to 
that, the nonglabrous skin (dorsal area of hand, foot) has more superficial nutritive 
(NUTR) perfusion through small capillaries with fewer AVA and is controlled by both 
the sympathetic vasoconstrictor and vasodilator nerves (15), (20). These differences may 
lead to differential SBF rates.  
Resting skin blood flow in a thermoneutral environment is about 5%-10% of 
cardiac output (250 mL/min) (9), (21). This is because of the dominant activity of the 
vasoconstrictor system in thermoneutral environments (22). The skin reaches about 50%-
70% of cardiac output (6 to 8 L/min) during exercise or heat exposure (9), (21). The 
sympathetic vasodilator system is not active during normothermia but activated only 
during hyperthermia. The larger increase in the skin circulation during hyperthermia is 
primarily achieved by activation of the sympathetic vasodilator nerves (80%-90%) and to 
a smaller extent by withdrawal of the sympathetic vasoconstrictor nerves (10%-20%) (15), 
(23), (9). Thus, subtle changes in the skin circulation play a crucial role in maintaining the 
normal human temperature (homeostasis) through heat dissipation (cutaneous 
vasodilation and sweating) and heat generation (9). For example, a rise of as little as 8 ml 
per 100 ml/min over the entire body surface from the neutral level can double the heat 
transfer to the environment (24).  
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Aging, body mass index (BMI), and diabetes impair the function of endothelial 
cells and autonomic nervous system, hence decreases microcirculation (10), (25), (26). 
Inabilities of the blood vessels to vasodilate in type 2 diabetes impair the normal heat 
dissipation and increase the risk of heat exhaustion (9), (27), (28).  Researchers believe SBF 
has no significant impact on the baroreflex control of BP unlike the skeletal muscles (29). 
However, baroreceptor reflex is an important mechanism that rapidly adjusts BP changes. 
Receptors in the carotid sinus and aortic arch carry the afferent information to the nucleus 
tractus solitarii (NTS). Short interneurons connect the NTS to the dorsal motor nucleus of 
the vagus and nucleus ambiquus (parasympathetic efferent), and rostral ventrolateral 
medulla oblongate (sympathetic efferent). A rise in the BP stimulates the baroreceptors 
and in turn increases the vagal tone and decreases the sympathetic tone. The opposite 
happens when there is a decrease in the BP (30). In recent years, research studies 
supported the role of sympathetic vasodilator and vasoconstrictor systems in the BP 
regulation (21), (31), (32), (33), (34). For example, the skin vasoconstrictor system was active 
when unloading of baroreceptors was achieved using lower-body negative pressure. 
However, skin circulation is low in thermoneutral environments. During hyperthermia, 
the vasodilator system is active and skin receives 50%-70% of cardiac output. Studies 
show that skin vasoconstricts through withdrawal of the vasodilator system when lower 
body negative pressure is applied during hyperthermia (21), (32). This implies that 
sympathetic activity in skin plays an integrated role in thermoregulation and the 
regulation of blood pressure. Impairment in one system can affect the other system (9).  
In research, the use of passive vibration (PV) to improve skin blood flow (SBF) 
without increasing the risk of burns has been performed and supported. A series of 
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studies performed by Lohman et al and Maloney-Hinds et al showed that PV significantly 
improved SBF in hairy and non-hairy skin in healthy volunteers, healthy older 
individuals, good to fair glycemic control diabetics and non-diabetics (35), (36), (37), (38), (39), 
(40). However, there was no research study examining the effect of PV in increasing SBF 
in diabetics without affecting skin temperature and blood pressure. The purpose of this 
study was to examine the effect of PV on SBF, skin temperature (ST) and blood pressure 
(BP) in good glycemic control versus poor glycemic control diabetics. We hypothesized 
that SBF in the calf area and the foot area without significantly affecting the skin 
temperature and blood pressure would be higher in good glycemic control than in poor 
glycemic control type 2 diabetics as a result of passive vibration.  
 
Material and Methods 
 
Study Population 
 
Type 2 diabetics between the age ranges of 18-75 years were invited to participate 
in this study. Subjects with neurological disorders, orthopedic disorders, bleeding 
disorders, leg ulcer, chronically exposed to vibration, cardiovascular diseases, possible 
deep vein thrombosis (DVT) with a score of 2 (high risk) in well’s criteria (41) or pregnant 
were excluded. Thirty seven subjects were recruited through fliers and word of mouth, 
and from the Diabetes Support Group and from the Diabetes Treatment Center at Loma 
Linda University (LLU) Medical Center. Five subjects were excluded because they did 
not meet the inclusion criteria. All the subjects were assigned to one of two groups: 
Group 1=Good glycemic control and Group 2=Poor glycemic control. Subjects received 
passive vibration to their calf and the opposite foot on the same day. All procedures were 
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approved by the LLU’s institutional review board and each subject signed a statement of 
informed consent (Appendix A). 
 
Instrumentation 
 
A Physio Plate® (Domino S.R.L, San Vendemiano, Italy) was used to deliver 
passive vibration at a frequency of 50 Hz for a total number of ten cycles (one cycle= 60s 
working time: 2s rest time) or approximately ten minutes (Figure 9). Skin blood flow was 
measured non-invasively by using a MOOR Full-field Laser Perfusion Imager (FLPI) 
(MOOR FLPI V 2.1, Oxford, England) that was pre-warmed for about 30 minutes 
(Figure 10). It uses a red light laser beam (632.8 nm) applied perpendicularly to capture 
SBF and the blood flow was measured in “Flux” unit. Skin temperatures were measured 
using a thermistor placed on the muscle belly of posterior calf muscle and on the plantar 
aspect of the first three metatarsal heads (Figure 11). The thermistor was manufactured 
by BioPac systems (BioPac Inc., Goleta, CA) and the output was sensed by an SKT 100 
thermistor amplifier. This analog data was converted into a digital data by the BioPac 
systems (BioPac Inc., Goleta, CA). A mean temperature was taken to analyze the data. 
Blood pressure at the brachial artery was measured using a blood pressure cuff monitor 
(RITE AID, Camp Hill, PA) (Figure 12). 
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Figure 9. Physio Plate® vibration platform. 
 
 
Figure 10. MOOR FLPI. 
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Figure 11. Thermistor. 
 
 
Figure 12. Blood pressure measurement. 
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Procedure 
 
Screening 
 
The testing room temperature was maintained between 71.6°F-75.2°F (22°-24° C) 
for about 30 minutes before the subjects enters. Subjects were asked to take rest in supine 
position for about 30 minutes to stabilize their blood flow before intervention. Subjects 
were screened for exclusion and demographic data was collected (Appendix B).  
Cutaneous sensation was assessed using a Semmes-Weinstein Monofilament 
(North Coast Medical, Inc, Morgan Hill, CA, USA) and the response, color of the handle 
and notations were noted on the sensory foot mapping form (Appendix C). Vibration 
sense was assessed using a 128 Hz tuning fork and subjects with a score of 2 (absent 
sensation) were excluded. 
 
Testing 
 
A square shaped 3 cm x 3 cm area was marked on the posterior aspect of the calf 
(muscle belly) and on the plantar aspect of the first three (1-3) metatarsal heads while the 
subjects were in prone position on a plinth. Baseline SBF, ST and BP was measured. 
Then, subjects received passive vibration to their calf for about ten minutes (Figure 13). 
The second reading was taken immediately after vibration. Subjects were given a ten 
minutes rest before the third reading was taken. The same procedures were repeated for 
foot on the opposite leg (Figure 14). 
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Figure 13. Calf area vibration. 
 
 
Figure 14. Foot area vibration. 
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Data Analysis 
 
Data was analyzed using SPSS version 20.0 (42). The distributions of the 
continuous variables were examined using one sample Kolmogorov Smirnov test. The 
proportions of males & females, ethnicity and levels of physical activity by group were 
compared using chi-square test of independence. We compared mean age and body mass 
index (BMI) by group using independent t-test. Mixed factorial analysis of variance was 
used to compare the effect of passive vibration on SBF, ST and BP from baseline to post 
vibration and 10 minutes post rest in good glycemic control and poor glycemic control 
Type 2 diabetic subjects’ calf and foot. Significant differences were further examined 
with Bonferroni test. The level of significance was set at p<.05.  
 
Results 
 
Seventeen good and fifteen poor glycemic control type 2 diabetics participated in 
this study. The results of the Kolmogorov Smirnov test showed that the distribution of 
age, BMI and SBF were approximately normal. Results showed that there were no 
significant differences between the good glycemic control and poor glycemic control 
diabetics in terms of gender, race, physical activity, age and BMI (p>.05) (Table 3). 
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Table 3. Distribution of demographic data by group (N=32).  
Variables  Good (n=17) Poor (n=15) p-value 
Gender† Male 10 (58.8%) 7 (41.2%) .49 
Female 7 (46.7%) 8 (53.3%)  
Ethnicity† White 7 (63.6%) 4 (36.4%) .37 
Others¶ 3 (30%) 7 (70%)  
Hispanic 4 (66.7%) 2 (33.3%)  
African American 3 (60%) 2 (40%)  
Physical activity† 
 
Very light 3 (30%) 7 (70%) .15 
Light 6 (75%) 2 (25%)  
Moderate & Heavy 8 (57.1%) 6 (42.9%)  
Age (Mean±SD)*  61.5±11.5 56.1±7.2 .12 
BMI (Mean±SD)*  30.7±5.6 32.3±6.5 .47 
†: Chi-square test 
*: Independent t test 
¶: Others: Asians, Middle eastern 
 
Skin Blood Flow 
 
Good Glycemic Control 
 
A significant change in mean calf SBF was observed over time in good glycemic 
control diabetics (F2, 32=6.53, p=.02) (Table 4). A significant change was detected 
between baseline and immediately after vibration (p=.03) and between baseline and 10 
minutes post rest (p=.03). However, the mean foot SBF did not significantly changed 
over time in good glycemic control diabetics (F2, 32=2.9, p=.09). The mean SBF was 
significantly higher in foot than in calf in the good glycemic control at baseline 
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(130.4±22.2 vs 38.8±2.2; p<.01), immediately after vibration (181.0±28.0 vs 67.5±12.0; 
p<.001) and 10 minutes post rest (139.3±20.6 vs 65.1±11.0; p<.01) (Figure 15). 
 
 
 
Figure 15. Changes in mean±SE† SBF† by site in good glycemic control 
diabetics over time. 
†SBF: Skin blood flow 
†SE: Standard error 
 
Poor Glycemic Control 
 
A significant change in mean calf SBF was observed over time in poor control 
diabetics    (F2, 28=12.1, p=.01) (Table 4). A Significant change was observed between 
baseline and immediately after passive vibration (p=.01) and between baseline and 10 
minutes post rest (p=.01). There was no significant change in mean foot SBF over time in 
poor glycemic control diabetics (F2, 28=.07, p=.86). The mean SBF was significantly 
higher in foot than in calf in poor glycemic control at baseline (140.0±28.6 vs 31.7±2.3; 
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p<.01), immediately after vibration (146.9±27.8 73.4±12.7; p=.03) and 10 minutes post 
rest (145.1±31.0 vs 67.6±10.5; p=.03) (Figure 16). 
 
 
 
Figure 16. Changes in mean±SE† SBF† by site in poor glycemic control 
diabetics over time. 
†SBF: Skin blood flow 
†SE: Standard error 
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Table 4. Mean (SE†) skin blood flow over time by group and site. 
Site Group Baseline Immediately 
after 
vibration 
10 min post 
rest 
p-value* 
Calf 
Good 38.8(2.20) 67.5(12.0) 65.1(11.0) .02 
Poor 31.7(2.3) 73.4(12.7) 67.6(10.5) <.01 
Foot 
Good 130.4(22.2) 181.0(28.0) 139.3(20.6) .09 
Poor 140.0(28.6) 146.9(27.8) 145.1(31.0) .86 
*Analysis of variance 
†SE: Standard error 
 
Good Glycemic Control vs. Poor Glycemic Control 
 
There was a significant difference in mean calf SBF over time in both good and 
poor glycemic control diabetics (F2, 60=18.20, p<.001). Based on the Bonferroni test, 
there was a significant difference in calf SBF between baseline and immediately after 
vibration (p<.001) and between baseline and 10 minutes post rest (p<.001) in both good 
glycemic control and poor glycemic control diabetics. There was no significant 
interaction between calf SBF and group (F2, 60=.56, p=.49).  In addition, there was no 
significant difference between groups (F1, 30=.01, p=.97). There was no significant 
difference in mean calf SBF between immediately after vibration and 10 minutes post 
rest (p=.40). There was no significant difference in foot SBF over time in both good 
glycemic control and poor glycemic control diabetics (F2, 60=2.0, p=.16). There was no 
significant interaction between foot SBF and group (F2, 60=1.31, p=.27). Also, there was 
no significant difference in mean foot SBF between groups (F1, 30=.04, p=.85). 
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Skin Temperature 
Good Glycemic Control 
 
There was no significant change in mean calf ST over time in good glycemic 
control diabetics (F2, 32=0.53, p=.50) (Table 5). However, a significant change was 
detected in mean foot ST over time in good glycemic control diabetics (F2, 32=6.1, p<.01). 
There was a significant change detected between baseline and immediately after vibration 
(p=.02), and between immediately after vibration and 10 minutes post rest (p=.04). There 
was a significant difference in mean ST between calf and foot in good glycemic control 
diabetics at baseline (t16=5.2, p<.001), immediately after vibration (t16=4.8, p<.001) and 
10 minutes post rest (t16=5.5, p<.001). The mean ST in the good glycemic control was 
significantly higher in calf than in foot at baseline (88.5±0.8 vs 84.2±0.7; p<.001), 
immediately after vibration (88.6±0.3 vs 85.6±0.6; p<.001) and 10 minutes post rest 
(87.9±0.4 vs 84.6±0.7; p<.001) (Figure 17). 
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Figure 17. Changes in mean±SE† ST† by site in good glycemic control 
diabetics over time .  
†SE: Standard error 
†ST: Skin temperature 
 
 
Poor Glycemic Control 
 
There was no significant change in mean calf ST over time in poor glycemic 
control diabetics (F2, 28=2.2, p=.13) (Table 5). Also, there was no significant change in 
mean foot ST over time in poor glycemic control diabetics (F2, 28=2.5, p=.10). However, 
there was a significant difference in mean ST between calf and foot in the poor glycemic 
control diabetics at baseline (t14=3.4, p<.01), immediately after vibration (t14=2.7, p=.02), 
and 10 minutes post rest (t14=3.1, p=.01). The mean ST in the good glycemic control was 
significantly higher in calf than in foot at baseline (87.3±0.3 vs 84.8±0.8; p<.01), 
immediately after vibration (88.0±0.4 vs 86.2±0.8; p=.02), and 10 minutes post rest 
(87.5±0.5 vs 85.4±0.7; p<.01) (Figure 18). 
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                  Figure 18. Changes in mean±SE† ST† by site in poor glycemic control 
diabetics. 
†SE: Standard error 
†ST: Skin temperature 
 
Table 5. Mean (SE†) skin temperature over time by group and site. 
Site Group Baseline 
Immediately 
after 
vibration 
10 min post 
rest p-value* 
Calf 
Good 88.5(0.3) 88.0(0.4) 87.5(0.5) .50 
Poor 87.3(2.6) 77.9(15.5) 70.9(12.5) .13 
Foot 
Good 84.2(0.7) 85.6(0.6) 84.6(0.7) <.01 
Poor 84.8(0.8) 86.2(0.8) 85.4(0.7) .10 
*Analysis of variance 
†SE: Standard error 
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Good Glycemic Control vs. Poor Glycemic Control 
 
There was no significant difference in mean calf ST over time in both good 
glycemic control and poor glycemic control diabetics (F2, 60=1.11, p=.31). Also, there was 
no significant interaction between group and calf temperature (F2, 60=0.45, p=.55). There 
was no significant difference between groups (F1, 30=1.79, p=.19). However, there was a 
significant difference in mean foot ST over time in both good glycemic control and poor 
glycemic control over time (F2, 60=7.3, p=.001).  Based on the Bonferroni test, there was a 
significant difference in foot ST between baseline and immediately after vibration 
(p=.002) and between immediately after vibration and 10 minutes post rest (p=.04) in 
both good glycemic control and poor glycemic control diabetics. There was no significant 
interaction between foot ST and group (F2, 60=0.07, p=.93). There was no significant 
difference in mean foot ST between groups (F1, 30=.54, p=.47).    
 
Blood Pressure 
 
Systolic Blood Pressure  
 
Good Glycemic Control 
There was no significant change in mean systolic blood pressure (SBP) over time 
during calf vibration in good glycemic control diabetics (F2, 32=4.2, p=.06) (Table 6). 
There was no significant change in mean SBP over time during foot vibration in good 
glycemic control diabetics (F2, 32=.8, p=.44). There was a significant difference in mean 
SBP between calf and foot in the good glycemic control diabetics at immediately after 
vibration (p=.01). However, there was no significant difference in mean SBP between 
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calf and foot in the good glycemic control at baseline (p=.23) and 10 minutes post rest 
(p=.1). 
 
Poor Glycemic Control  
There was no significant change in mean SBP over time during calf vibration in 
poor glycemic control diabetics (F2, 28=.5, p=.54) (Table 6). There was no significant 
change in mean SBP over time during foot vibration in poor glycemic control diabetics 
(F2, 28=.2, p=.76). There was no significant difference in mean SBP between calf and foot 
in the good glycemic control diabetics at baseline (p=.83), immediately after vibration 
(p=.65) and 10 minutes post rest (p=.13). 
 
Table 6. Mean (SE†) systolic blood pressure over time by group and site. 
Site Group Baseline 
Immediately 
after 
vibration 
10 min post 
rest p-value* 
Calf 
Good 124.7(2.4) 131.8(4.5) 128.5(3.4) .06 
Poor 128.1(3.2) 128.7(4.7) 131.3(3.4) .54 
Foot 
Good 122.5(2.3) 124.9(3.3) 124.7(2.4) .44 
Poor 127.7(4.0) 126.7(2.8) 128.1(3.2) .76 
*Analysis of variance 
†SE: Standard error 
 
Good Glycemic Control vs. Poor Glycemic Control 
There was no significant difference in mean calf SBP over time in both good 
glycemic control and poor glycemic control diabetics (F2, 60=2.1, p=.15). Also, there was 
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no significant interaction between group and calf SBP (F2, 60=1.5, p=.23). There was no 
significant difference between groups (F1, 30=.1, p=.82). There was no significant 
difference in mean foot SBP over time in both good glycemic control and poor glycemic 
control diabetics (F2, 60=.3, p=.67). There was no significant interaction between foot SBP 
and group (F2, 60=.5, p=.54). There was no significant difference in mean foot SBP 
between groups (F1, 30=.8, p=.37).    
 
Diastolic Blood Pressure  
 
Good Glycemic Control 
There was no significant change in mean diastolic blood pressure (DBP) over 
time during calf vibration in good glycemic control diabetics (F2, 32=.9, p=.34) (Table 7). 
There was no significant change in mean DBP over time during foot vibration in good 
glycemic control diabetics (F2, 32=5.5, p=.39). There was no significant difference in 
mean DBP between calf and foot in the good glycemic control at baseline (p=.53), 
immediately after vibration (p=.29) and 10 minutes post rest (p=.36). 
Poor Glycemic Control 
There was no significant change in mean DBP over time during calf vibration in 
poor glycemic control diabetics (F2, 28=4.8, p=.05) (Tabel 7). There was no significant 
change in mean DBP over time during foot vibration in poor glycemic control diabetics 
(F2, 28=1.0, p=.37). There was no significant difference in mean DBP between calf and 
foot in the poor glycemic control diabetics at baseline (p=.11) and immediately after 
vibration (p=.50). However, there was a significant difference between calf and foot at 10 
minutes post rest (p=.02) (Figure 2). 
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Table 7. Mean (SE†) diastolic blood pressure over time by group and site. 
Site Group Baseline 
Immediately 
after 
vibration 
10 min post 
rest p-value* 
Calf 
Good 74.1(1.7) 75.8(1.8) 75.6(1.5) .43 
Poor 79.6(1.8) 78.7(1.4) 83.3(1.8) .05 
Foot 
Good 73.2(1.2) 74.2(1.4) 74.1(1.7) .39 
Poor 77.7(2.0) 80.1(1.7) 79.6(1.8) .37 
*Analysis of variance 
†SE: Standard error 
 
 
Good Glycemic Control vs. Poor Glycemic Control 
There was no significant difference in mean calf DBP over time in both good 
glycemic control and poor glycemic control diabetics (F2, 60=3.4, p=.07). Also, there was 
no significant interaction between group and calf DBP (F2, 60=2.6, p=.08). However, there 
was a significant difference between groups (F1, 30=7.2, p=.01). There was no significant 
difference in mean foot DBP over time in both good glycemic control and poor glycemic 
control diabetics (F2, 60=1.4, p=.26). There was no significant interaction between foot 
DBP and group (F2, 60=.2, p=.83). However, there was a significant difference in mean 
foot DBP between groups (F1, 30=7.4, p=.01).    
 
Discussion 
 
Body temperature, skin blood flow (SBF) and blood pressure (BP) measurements 
can provide important information about the status of the cardiovascular and 
thermoregulatory systems. They provide the body’s physiological status and their 
62 
response to various stimuli such as physical activity, stress and environmental influences 
(43). Studies from the Department of Physical Therapy in the Loma Linda University and 
others have shown that vibration can be effective in increasing SBF in diabetics as well 
as in non-diabetics (38), (36), (37), (35), (39), (44), (45), (46), (47).  
Results of this study showed that the mean SBF in the hairy skin (calf) was 
improved in both good glycemic control and poor glycemic control diabetics. This 
improvement was detected from baseline to immediately after vibration, and from 
baseline to 10 minutes post vibration intervention with no significant increase in the ST 
and SBF. There was a significant difference in the mean DBP between the groups. 
However, the mean difference is 5.3 mm of Hg and can be considered clinically not 
significant. The increase in mean calf SBF was almost doubled between baselines (38.8) 
to immediately after vibration (67.5) and to 10 minutes post rest (65.1) in the good 
glycemic control diabetics. The increase in mean calf SBF was more than doubled from 
baseline (31.7) to immediately after vibration (73.4) and to 10 minutes post rest (67.6) in 
the poor glycemic control diabetics. However, the percent change in calf SBF was higher 
in the poor glycemic control (131.6%) than the good glycemic control diabetics (71.2%) 
between baseline to immediately after vibration. No significant difference in the mean 
calf SBF between immediately after vibration to 10 minutes post rest in both the groups 
were detected, suggesting that both groups responded to passive vibration similarly. The 
calf SBF remained elevated at ten minutes post PV and was beginning to decline in both 
the groups.  
In contrast to the hairy skin (calf), the foot (non hairy) showed no significant 
increase in mean SBF across time in and between both good glycemic control and poor 
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glycemic control diabetics. However, the highest percent change in the foot SBF was 
seen in good glycemic control (91.3%) as compared to poor glycemic control (32.6%). 
Although the percent change is less in poor glycemic control, we agree with 
Wiernsperger and Bouskela that distribution of blood in the microvascular bed is the 
primary factor and not the quantity (8). The foot of the good glycemic control diabetics 
showed a mean temperature difference of 1.2°F. A mean temperature change of 1.2°F 
was not considered clinically significant although it was statistically significant. We did 
not notice any clinically significant rise or fall in the mean systolic and diastolic blood 
pressure in both groups.  
These findings suggest that passive vibration can be used to improve SBF in the 
calf and foot without the risk of increasing skin burns, heat exhaustion and cardiovascular 
stress in both good glycemic control and poor glycemic control type 2 diabetics. 
 
Conclusion 
 
Based on the findings, we suggest that passive vibration can be safely 
administered to calf and foot without increasing the risk of burns; heat exhaustion and 
increase in blood pressure in both good glycemic control and poor glycemic control type 
2 diabetics. 
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CHAPTER FOUR 
 
SUMMARY 
 
 
Diabetes Mellitus 
 
Diabetes Mellitus is a group of metabolic disorder resulting from no insulin or 
decreased insulin production from the pancreas. This can impair carbohydrate, fat and 
protein metabolism and leads to abnormal glucose levels in the blood stream (1). In some 
instances, the body ineffectively use insulin produced by the pancreatic cells. This leads 
to build up of abnormal glucose levels in blood stream instead of being absorbed by body 
cells. Overtime, the beta cells in the body loses its ability to produce enough insulin for 
the cells to absorb glucose, leading to insulin resistance (2). Aging and diabetes can 
damage the autonomic nervous system and the endothelial lining of the blood vessels. 
These damages reduce the release of vaso dilator substances such as prostacyclin and 
nitric oxide (NO) (3), (4) . As a result, the balance between the vasodilators and 
vasoconstrictors substances is impaired in the endothelial cells leading to increased 
vasoconstriction. This reduces the resting skin blood flow (4). One of the important 
functions of the skin is the regulation of temperature in the human body. 
Thermoregulation helps to maintain the balance between heat generation and heat 
dissipation during thermoneutral environment and during hyperthermia. This is achieved 
by the sympathetic vasodilator and vasoconstrictor systems. The ability to vasodilate is 
impaired in diabetes. This most likely reduces the ability of the blood vessels to dissipate 
heat during elevated temperature in the environments (5). 
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Impaired skin microcirculation can lead to decreased nutrients to the epidermis 
and reduces the exchange of waste products with epidermis. Therefore, damage to micro 
vascular bed and associated reduction in the skin circulation plays a significant role in the 
insulin metabolism (6) and  rate of wound healing (7). 
 
Vibration 
 
Vibration is an intervention that increases skin blood flow in the healthy and 
diabetic individuals without increasing the risk of burns. The effect on the human body as 
a result of vibration, is not only biomechanical but also physiological (8). Vibration can be 
delivered parallel to the blood vessels (longitudinal) or lateral to the blood vessels 
(perpendicular). This can cause shear stress to both the larger and smaller vessels. 
Increased external pressures as a result of perpendicular vibration can damage endothelial 
tissues on the blood vessels. One of the important effects of lateral vibration 
(perpendicular) in small vessels (arterioles, capillaries, venules) is the deformation of the 
blood vessels. Thus, vibration can change the shape of the blood vessels from circular 
into more or less elliptical. This change of shape from circular to elliptical can increase 
total peripheral resistance (TPR).  
A study performed by Mester et al., (2006) showed that the TPR was significantly 
reduced after the application of vibration (8). Mester et al., (2006) suggested that the 
decrease in TPR during vibration can be achieved by opening of more capillaries or 
dilatation of blood vessels or both (8).  Mester et al., (2006) proposed that safety during 
the application of therapeutic vibration should be considered to avoid various damages 
that may cause headache, internal bleeding or even death (8). This can be avoided by 
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following the guidelines associated with vibration parameters. However, more research 
studies have to be done to establish guidelines for parameters such as the frequency, 
amplitude, duration of the each vibration application, resting interval, total duration of the 
vibration application and position of the body. 
 
Studies form the Department of Physical Therapy 
 
A series of studies have been conducted from the Department of Physical 
Therapy, Loma Linda University (LLU) to examine the effect of a specific frequency and 
specific time in improving SBF due to active and passive vibration in healthy, diabetic 
and non diabetic individuals.  
In the first study, forty five healthy subjects aged between 18-43 years 
participated and were randomly divided into one of three groups: Group 1=isometric 
weight bearing exercise (vibration exercise), Group 2=exercise only and Group 
3=vibration only. Initial baseline SBF was measured using a laser Doppler imager 
produced by MOOR Instruments, Inc (LDV 304, Oxford, England). Then, the subjects 
according to their assigned group performed isometric therapeutic exercise with or 
without whole body vibration or received vibration to their calf using Power Plate® 
vibration platform (Power Plate® North America, LLC, Culver City, California, USA). 
Skin blood flow was measured immediately after the intervention. The third measurement 
was taken after ten minutes of rest. The authors reported that the group that received 
vibration only showed significant increase in blood flow from baseline to post vibration 
(250%) and remained elevated at 10 minutes post intervention (200%) (9). 
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In the second study, the authors utilized two experiments to assess if a specific 
frequency or a specific duration of vibration was better in improving SBF. In first 
experiment, they selected 18 healthy subjects (mean age 20.3±2.9 years) and randomly 
placed them into 30Hz or 50Hz vibration group. In the second experiment, seven subjects 
(mean age 23.3±3.8 years) received 30 Hz vibration on one day and were asked to come 
the next day to receive 50 Hz. In both of these experiments, subjects received vibration to 
the underside of their forearm for 10 minutes using a vibration platform (Power Plate® 
North America, LLC, Culver City, California, USA). Subjects were instructed not to have 
eaten two hours prior to the vibration intervention. Skin blood flow was measured using 
laser Doppler flow meter (BioPac Systems, Golletta, CA) at baseline, during vibration 
and 15 minutes of recovery period.  
Findings from the first experiment showed that SBF remained significantly 
elevated from fourth minute until the ninth minute in both 30Hz and 50Hz group. There 
was a significant decrease (90%, p=0.01) in SBF between the ninth minute to tenth 
minute of vibration. In addition to that, the fifth minute showed the highest percent 
increase in 50Hz (511%) vs. 30Hz (360%) groups. During the 15 minutes recovery 
period, SBF in the 30Hz group dropped below baseline (mean=78%) at the ninth minute 
and reached its lowest point (mean=74%) at the 15 minute recovery period. However, 
SBF in the 50Hz group did not return to the baseline (mean=128%) within the 15 minute 
recovery.  
Results of the second experiment showed that significant increase was seen at the 
fourth minute in both 30Hz (293%) and 50Hz (513%) frequencies. Skin blood flow was 
higher throughout the vibration treatment and two minutes after. Skin blood flow in the 
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30Hz reached baseline (99%) at minute 5 of recovery, increased to 184% at minute 6. It 
continued to drop after ninth minute and reached to 65% of baseline at minute 15 of 
recovery. However, SBF in 50 Hz did not return to baseline (140%) and remained 
elevated during the 15th minute recovery period. Study findings from these two 
experiments suggested that passive vibration with a frequency of either 30 Hz or 50 Hz 
can significantly increase skin blood flow in the forearm within five minutes of passive 
vibration application. Based on the two experiments, the authors reported that passive 
vibration was quick and a feasible method to increase skin blood flow in a short period of 
time as opposed to the other methods that can lead to skin burns (hot packs), side effects 
(medications) or discomfort (exercise) (10). 
In another study, ten type 2 diabetics with an average HbA1c level of 6.5% and 
ten age and body mass index (BMI) matched healthy adults, were tested. Subjects 
received vibration to their forearm using the Power Plate® (Power Plate® North America, 
LLC, Culver City, California, USA). Skin blood flow and blood concentrations of nitric 
oxide (NO) were measured at baseline, immediately after 5 minutes of vibration and 5 
minutes after vibration was ceased. Skin blood flow was measured by using a laser 
Doppler meter (BioPac Systems, Golletta, CA). Results from this study showed that SBF 
was significantly increased in both healthy adults (461%) and type 2 diabetics (223%). 
Blood concentrations of NO was significantly higher in both the healthy group (374%) 
and the type 2 diabetics (258%) without any significant difference between the two 
groups (11).  
In another study, ten healthy adult volunteers aged between 20-30 years 
participated, and received two interventions a day for 3 consecutive days: Intervention 1 - 
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active vibration only (vibration exercise), Intervention 2-passive vibration only, 
Intervention 3 - moist heat only, Intervention 4 – moist heat combined with passive 
vibration (MHPV), Intervention 5 – a commercial Sunbeam® Health at Home® 
massaging heating pad, and Intervention 6 - no intervention, rest. Power Plate® (Power 
Plate® North America, LLC. Culver City, California, USA) was used to deliver vibration. 
Skin blood flow and skin temperature was measured on the posterior aspect of the muscle 
belly of gastrocnemius at baseline, immediately after vibration and 10 minutes post 
vibration. Skin blood flow and skin temperature were measured using a laser Doppler 
flow meter produced by BioPac, Inc (BioPac Systems, Golletta, CA). The MHPV 
combination showed highest increase in SBF than in the passive vibration alone and 
moist heat alone groups from baseline to immediately after vibration. At the same time, 
increase in skin temperature was lowest in the MHPV combination group than in passive 
vibration alone and the moist heat alone groups. However, the passive vibration alone 
group showed significant increase in skin blood flow without significant increase in skin 
temperature as opposed to the moist heat alone group. These findings indicated that 
passive vibration can be a safe alternative method in increasing SBF in individuals at a 
greater risk of a burn (12). 
In the follow up study, ten healthy elderly subjects between 55-73 years of age 
received two interventions for ten minutes each day for three consecutive days: 
Intervention 1- active vibration, Intervention 2- passive vibration, Intervention 3 – moist 
heat, Intervention 4 – moist heat combined with passive vibration (MHPV), Intervention 
5 – a commercial Sunbeam® Health at Home® Massaging Heating Pad, and Intervention 
6- rest. Passive vibration was delivered using the Physio Plate® (GLOBUS Physio Plate, 
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Domino S.R.L, San Vendemiano, Italy). Skin blood flow was measured using a laser 
Doppler imager (MOOR FLPI, V 2.1. Oxford, England). Skin temperature was measured 
using a thermistor (BioPac®, Inc, Goleta, California). Measurements were taken at 
baseline, immediately after vibration and 10 minutes post vibration. Results showed that 
the MHPV combination significantly increased SBF to 450% immediately after ten 
minutes of vibration and to 379% at 10 minutes post rest; more than any other 
interventions. A significant change in ST was found in the MHPV combination than the 
other interventions. Findings from this study showed that passive vibration can increase 
skin blood flow without increasing skin temperature in elderly individuals (13).  
In another study, the authors examined the effect of PV with a frequency of 50 
HZ in improving skin blood flow in type 2 diabetics. Eighteen subjects with type 2 
diabetes mellitus between 47-74 years of age, and 18 age matched controls between 50-
75 years of age received 10 minutes of PV. Passive vibration was delivered to the anterior 
aspect of their forearm and on the plantar aspect of the first three metatarsal heads using a 
vibration platform (GLOBUS Physio Plate, Domino S.R.L, San Vendemiano, Italy). Skin 
blood flow was measured at baseline, post vibration and 10 minutes post rest using a laser 
Doppler imager (MOOR FLPI, V 2.1. Oxford, England). Findings showed that there was 
a significant difference in the foot and forearm SBF across time for both groups. 
Diabetics showed the greatest percent increase in the foot SBF (118.5%) from baseline to 
end of vibration vs. non diabetics (37.62%). However, there was no significant change in 
mean SBF in forearm vs. foot across time between groups. Study findings suggested that 
passive vibration can increase SBF in type 2 diabetics (14).  
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Conclusion 
 
Overall, the study findings from the Department of Physical Therapy, LLU 
suggest that: 1) Passive vibration is a safe method as opposed to other methods such as 
hot packs, medications and exercise in increasing skin blood flow in the individuals who 
are at a greater risk of burns, 2) Passive vibration can increase skin blood flow in healthy 
younger adults, healthy elderly and type 2 diabetics, 3) Passive vibration can significantly 
increase SBF in the forearm and foot with the subjects in the sitting position and in the 
calf area with the subjects in the lying position,  4) Significant increase in SBF can be 
obtained within five minutes of vibration, 5) SBF can remain elevated for at least nine 
minutes during the vibration application, 6) SBF remains elevated for at least seven 
minutes following the vibration application, and 7) The combination of moist heat and 
passive vibration can significantly increase SBF in the calf area without significantly 
increasing skin temperature.  
Several lines of evidence suggest that clinicians can use passive vibration to 
improve skin microcirculation (6), (9), (10), (11),  (12), (13), (14). This may reduce ulcer and other 
skin complications that are associated with aging and diabetes. Clinical trials are needed 
to determine the possibility of reducing diabetic ulcer as a result of passive vibration.  
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Demographic Data
Informed Consent:  Yes  No  (Circle Correct Response) 
 
Subject Identification Number: 
Age:  Gender:  Height: Weight: 
Physical Activity:                                     Very Light/  Light/  Moderate/  Heavy/  Exceptional 
Ethnicity:  American Indian or Alaska Native/ Asian/ Black or African American/ Hispanic or Latino/ Native 
Hawaiian or Other Pacific Islander/ White/ Other:  
Exclusion                     Comments 
Circulatory disorders 
 
Yes (     )  No (     ) 
Deep vein thrombophlebitis or other bleeding disorders Yes (     ) No (     ) 
Pregnant    Yes (     ) No (     ) 
Is it possible that you may be pregnant Yes (     ) No (     ) 
Pacemakers  Yes (     ) No (     ) 
Cancer  Yes (     ) No (     ) 
History of Heart Disease  Yes (     ) No (     ) 
Skin Ulcers  Yes (     ) No (     ) 
Neurological or Orthopaedic Disorders Yes (     ) No (     ) 
Homan’s Sign Test  +  ‐ 
Assess for pain, pallor, swelling, tenderness or warmth to palpation: Yes No 
Calf muscle girth  Right:              in/cm Left:            in/cm 
Well’s Clinical Prediction Rule for Deep Vein Thrombosis     Score 
Active cancer?  Yes (1 Points) 
Bedridden recently 3 days or major surgery within four weeks? Yes (1 Points)
Calf swelling 3 cm compared to the other leg Yes (1 Points)
Collateral (non‐varicose) superficial veins present? Yes (1 Points)
Entire leg swollen?  Yes (1 Points)
Localized tenderness along the deep venous system? Yes (1 Points)
Pitting edema, greater in the symptomatic leg? Yes (1 Points)
Paralysis, paresis, or recent plaster immobilization of the lower extremity Yes (1 Points)
Previously documented DVT?  Yes (1 Points)
Alternative diagnosis to DVT as likely or more likely Yes (‐2  Points)
       A score of ≥2 will be excluded from the study.                                           Total Score: 
 
Semmes‐Weinstein Test®: At test site location        (Circle one response) 
                                      2.83           3.61          4.31          4.56          5.07                    6.65    
A1c Level:  
Decision :           □   Include in the study                                        □                 Exclude in the study 
84 
APPENDIX C 
FOOT MAPPING FORM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
85 
Semms-Weinstein Monofilament – Sensory Foot Mapping 
Subject Number: 
Foot ‐ dorsal
 
Foot ‐ plantar
 
Evaluator size Target Force (g) Representation Dorsal Thresholds PlantarThresholds 
2.83 0.07 Green Normal Normal 
3.61 0.4 Blue Diminished 
light touch 
Normal 
4.31 2.0 Purple Diminished 
protective 
Diminished 
light touch 
4.56 4.0 Red Loss of 
protective 
Diminished 
protective 
5.07 10.0 Red Loss of 
protective 
Loss of 
protective 
6.65 300.0 Red Deep pressure 
only 
Deep pressure 
only 
Impressions: 
 
 
